Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 8/20 | 0.33 |
| ▸ | OGG1 | O15527 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 5/20 | 0.31 |
| ▸ | CYP27B1 | O15528 | 1/20 | 0.30 |
| ▸ | CASR | P41180 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3120732 | 0.79 | MEN1 (0.35) | MEN1ALDH1A1KMT2ACNR2OGG1 | |
| SCHEMBL10332003 | 0.78 | MEN1 (0.34) | MEN1ALDH1A1KMT2ACNR2OGG1 | |
| SCHEMBL10875973 | 0.77 | TDP1 (0.42) | MEN1ALDH1A1KMT2ACNR2CYP3A4 | |
| SCHEMBL29101228 | 0.76 | MEN1 (0.35) | MEN1ALDH1A1KMT2ACNR2OGG1 | |
| SCHEMBL1423791 | 0.74 | CNR2 (0.37) | MEN1ALDH1A1KMT2ACNR2OGG1 | |
| SCHEMBL1423792 | 0.74 | CYP27B1 (0.38) | MEN1ALDH1A1KMT2ACNR2OGG1 | |
| Hexaconazole SCHEMBL3224781 | 0.74 | CYP3A4 (0.50) | ALDH1A1KMT2ACYP3A4 | |
| Hexaconazole SCHEMBL3019086 | 0.74 | CYP3A4 (0.50) | ALDH1A1KMT2ACYP3A4 | |
| Hexaconazole SCHEMBL21992 | 0.74 | CYP3A4 (0.50) | ALDH1A1KMT2ACYP3A4 | |
| Hexaconazole SCHEMBL29795747 | 0.74 | CYP3A4 (0.50) | ALDH1A1KMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5385926-A | Wood preservative | BAYER AKTIENGESELLSCHAFT (DE) | 1995-01-31 | — | — | US | claimed |
| US-8603453-B2 | Antimicrobial polymeric biguanide and acidic co-polymer composition and method of use | ARCH UK BIOCIDES LIMITED (GB) | 2013-12-10 | — | — | US | disclosed |
| US-7851541-B2 | Composition and use | ARCH UK BIOCIDES LIMITED (GB) | 2010-12-14 | — | — | US | disclosed |
| EP-1635642-B1 | ANTIMICROBIAL COMPOSITION COMPRISING A POLYMERIC BIGUANIDE AND A COPOLYMER AND USE THEREOF | ARCH UK BIOCIDES LTD (GB) | 2010-07-07 | — | — | EP | disclosed |
| EP-1633192-B1 | ANTIMICROBIAL COMPOSITION COMPRISING A POLYMERIC BIGUANIDE AND A COPOLYMER AND USE THEREOF | ARCH UK BIOCIDES LTD (GB) | 2010-05-05 | — | — | EP | disclosed |
| US-20070203285-A1 | Composition and use | HODGE DAVID J | 2007-08-30 | — | — | US | disclosed |
| US-7226968-B2 | Composition and use | ARCH UK BIOCIDES LIMITED (GB) | 2007-06-05 | — | — | US | disclosed |
| US-7217759-B2 | Composition and use | ARCH UK BIOCIDES LIMITED (GB) | 2007-05-15 | — | — | US | disclosed |
| EP-1635642-A1 | ANTIMICROBIAL COMPOSITION COMPRISING A POLYMERIC BIGUANIDE AND A COPOLYMER AND USE THEREOF | Arch UK Biocides Limited (GB) | 2006-03-22 | — | — | EP | disclosed |
| EP-1633192-A1 | ANTIMICROBIAL COMPOSITION COMPRISING A POLYMERIC BIGUANIDE AND A COPOLYMER AND USE THEREOF | Arch UK Biocides Limited (GB) | 2006-03-15 | — | — | EP | disclosed |
| EP-1624755-A1 | COMPOSITION COMPRISING AN ACIDIC COPOLYMER AND AN ANTIMICROBIAL AGENT AND USE THEREOF | Arch UK Biocides Limited (GB) | 2006-02-15 | — | — | EP | disclosed |
| US-20050013794-A1 | Composition and use | ARCH UK BIOCIDES LIMITED (GB) | 2005-01-20 | — | — | US | disclosed |
| US-20050014670-A1 | Composition and use | ARCH UK BIOCIDES | 2005-01-20 | — | — | US | disclosed |
| US-20050009971-A1 | Composition and use | ARCH UK BIOCIDES | 2005-01-13 | — | — | US | disclosed |
| US-20050008534-A1 | Composition and use | ARCH UK BIOCIDES | 2005-01-13 | — | — | US | disclosed |
| WO-2004100666-A1 | ANTIMICROBIAL COMPOSITION CONTAINING A POLYMERIC BIGUADINE AND A COPOLYMER AND USE THEREOF | ARCH UK BIOCIDES LIMITED (GB) | 2004-11-25 | — | — | WO | disclosed |
| WO-2004100663-A1 | ANTIMICROBIAL COMPOPSITION COMPRISING A POLYMERIC BIGUANIDE AND A COPOLYMER AND THEIR USE THEREOF | ARCH UK BIOCIDES LIMITED (GB) | 2004-11-25 | — | — | WO | disclosed |
| WO-2004100664-A1 | COMPOSITION COMPRISING AN ACIDIC COPOLYMER AND AN ANTIMICROBIAL AGENT AND USE THEREOF | ARCH UK BIOCIDES LIMITED (GB) | 2004-11-25 | — | — | WO | disclosed |
| WO-2004100665-A1 | ANTIMICROBIAL COMPOSITION COMPRISING A POLYMERIC BIGUANIDE AND A COPOLYMER AND USE THEREOF | ARCH UK BIOCIDES LIMITED (GB) | 2004-11-25 | — | — | WO | disclosed |
| US-5200421-A | Synergistic combination of azole fungicide tebuconazole and 3-iodo-2-propargyl N-butylcarbamate | BAYER AKTIENGESELLSCHAFT (DE) | 1993-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050008534-A1 | Composition and use | TST, TH, ARG1 | MEN1 1211/4885ALDH1A1 244/4885KMT2A 2251/4885 |
| US-20050013794-A1 | Composition and use | H1-0, ARG1, C5 | MEN1 929/4885ALDH1A1 3642/4885KMT2A 3138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.